|Product name||Recombinant Human CD48/SLAMF2/BCM1 Protein|
|Description||Recombinant Human CD48/SLAMF2/BCM1 Protein is produced by HEK293 expression system. The target protein is expressed with sequence (Gln27-Ser220) of human CD48/SLAMF2/BCM1 (Accession #NP_001769.2) fused with an Fc, 6×His tag at the C-terminus.|
|Bio-Activity||Measured by its binding ability in a functional ELISA. Immobilized rh2B4/Fc Chimera at 5 μg/mL (100 μL/well) can bind Recombinant Human CD48/SLAMF2/BCM1 with a linear range of 0.06-4 μg/mL.|
|Purity||> 97% by SDS-PAGE.|
|Endotoxin||< 0.1 EU/μg of the protein by LAL method.|
|Formulation||Lyophilized from a 0.22 μm filtered solution of PBS, pH 7.4.|
|Synonym||BCM1; BLAST; BLAST1; hCD48; mCD48; MEM-102; SLAMF2|
|Expressed Host||HEK293 cells|
|Tag||Fc, 6×His tag at the C-terminus|
|Storage||Store the lyophilized protein at -20°C to -80 °C for long term. |After reconstitution, the protein solution is stable at -20 °C for 3 months, at 2-8 °C for up to 1 week.|
|Reconstitution||Reconstitute to a concentration of 0.1-0.5 mg/mL in sterile distilled water.|
Submit your question about RP00107 below and we will get back to you within one business day.
Alternatively, call us at 888.754.5670.